165 related articles for article (PubMed ID: 31146072)
1. REQUITE: A prospective multicentre cohort study of patients undergoing radiotherapy for breast, lung or prostate cancer.
Seibold P; Webb A; Aguado-Barrera ME; Azria D; Bourgier C; Brengues M; Briers E; Bultijnck R; Calvo-Crespo P; Carballo A; Choudhury A; Cicchetti A; Claßen J; Delmastro E; Dunning AM; Elliott RM; Fachal L; Farcy-Jacquet MP; Gabriele P; Garibaldi E; Gómez-Caamaño A; Gutiérrez-Enríquez S; Higginson DS; Johnson K; Lobato-Busto R; Mollà M; Müller A; Payne D; Peleteiro P; Post G; Rancati T; Rattay T; Reyes V; Rosenstein BS; De Ruysscher D; De Santis MC; Schäfer J; Schnabel T; Sperk E; Symonds RP; Stobart H; Taboada-Valladares B; Talbot CJ; Valdagni R; Vega A; Veldeman L; Ward T; Weißenberger C; West CML; Chang-Claude J;
Radiother Oncol; 2019 Sep; 138():59-67. PubMed ID: 31146072
[TBL] [Abstract][Full Text] [Related]
2. A Deep Learning Approach Validates Genetic Risk Factors for Late Toxicity After Prostate Cancer Radiotherapy in a REQUITE Multi-National Cohort.
Massi MC; Gasperoni F; Ieva F; Paganoni AM; Zunino P; Manzoni A; Franco NR; Veldeman L; Ost P; Fonteyne V; Talbot CJ; Rattay T; Webb A; Symonds PR; Johnson K; Lambrecht M; Haustermans K; De Meerleer G; de Ruysscher D; Vanneste B; Van Limbergen E; Choudhury A; Elliott RM; Sperk E; Herskind C; Veldwijk MR; Avuzzi B; Giandini T; Valdagni R; Cicchetti A; Azria D; Jacquet MF; Rosenstein BS; Stock RG; Collado K; Vega A; Aguado-Barrera ME; Calvo P; Dunning AM; Fachal L; Kerns SL; Payne D; Chang-Claude J; Seibold P; West CML; Rancati T
Front Oncol; 2020; 10():541281. PubMed ID: 33178576
[No Abstract] [Full Text] [Related]
3. External Validation of a Predictive Model for Acute Skin Radiation Toxicity in the REQUITE Breast Cohort.
Rattay T; Seibold P; Aguado-Barrera ME; Altabas M; Azria D; Barnett GC; Bultijnck R; Chang-Claude J; Choudhury A; Coles CE; Dunning AM; Elliott RM; Farcy Jacquet MP; Gutiérrez-Enríquez S; Johnson K; Müller A; Post G; Rancati T; Reyes V; Rosenstein BS; De Ruysscher D; de Santis MC; Sperk E; Stobart H; Symonds RP; Taboada-Valladares B; Vega A; Veldeman L; Webb AJ; West CM; Valdagni R; Talbot CJ;
Front Oncol; 2020; 10():575909. PubMed ID: 33216838
[No Abstract] [Full Text] [Related]
4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
5. Multi-centre technical evaluation of the radiation-induced lymphocyte apoptosis assay as a predictive test for radiotherapy toxicity.
Talbot CJ; Veldwijk MR; Azria D; Batini C; Bierbaum M; Brengues M; Chang-Claude J; Johnson K; Keller A; Smith S; Sperk E; Symonds RP; Wenz F; West CML; Herskind C; Bourgier C
Clin Transl Radiat Oncol; 2019 Sep; 18():1-8. PubMed ID: 31341970
[TBL] [Abstract][Full Text] [Related]
6. No Association Between Polygenic Risk Scores for Cancer and Development of Radiation Therapy Toxicity.
Barnett GC; Kerns SL; Dorling L; Fachal L; Aguado-Barrera ME; Martínez-Calvo L; Jandu HK; Welsh C; Tyrer J; Coles CE; Haviland JS; Parker C; Gómez-Caamaño A; Calvo-Crespo P; Sosa-Fajardo P; Burnet NG; Summersgill H; Webb A; De Ruysscher D; Seibold P; Chang-Claude J; Talbot CJ; Rattay T; Parliament M; De Ruyck K; Rosenstein BS; Pharoah PDP; Dunning AM; Vega A; West CML;
Int J Radiat Oncol Biol Phys; 2022 Nov; 114(3):494-501. PubMed ID: 35840111
[TBL] [Abstract][Full Text] [Related]
7. Independent validation of genes and polymorphisms reported to be associated with radiation toxicity: a prospective analysis study.
Barnett GC; Coles CE; Elliott RM; Baynes C; Luccarini C; Conroy D; Wilkinson JS; Tyrer J; Misra V; Platte R; Gulliford SL; Sydes MR; Hall E; Bentzen SM; Dearnaley DP; Burnet NG; Pharoah PD; Dunning AM; West CM
Lancet Oncol; 2012 Jan; 13(1):65-77. PubMed ID: 22169268
[TBL] [Abstract][Full Text] [Related]
8. The addition of androgen deprivation therapy and pelvic lymph node treatment to prostate bed salvage radiotherapy (NRG Oncology/RTOG 0534 SPPORT): an international, multicentre, randomised phase 3 trial.
Pollack A; Karrison TG; Balogh AG; Gomella LG; Low DA; Bruner DW; Wefel JS; Martin AG; Michalski JM; Angyalfi SJ; Lukka H; Faria SL; Rodrigues GB; Beauchemin MC; Lee RJ; Seaward SA; Allen AM; Monitto DC; Seiferheld W; Sartor O; Feng F; Sandler HM
Lancet; 2022 May; 399(10338):1886-1901. PubMed ID: 35569466
[TBL] [Abstract][Full Text] [Related]
9. Genome-wide association study of treatment-related toxicity two years following radiotherapy for breast cancer.
Jandu HK; Veal CD; Fachal L; Luccarini C; Aguado-Barrera ME; Altabas M; Azria D; Baten A; Bourgier C; Bultijnck R; Colciago RR; Farcy-Jacquet MP; Chang-Claude J; Choudhury A; Dunning A; Elliott RM; Green S; Gutiérrez-Enríquez S; Herskind C; Lambrecht M; Monten C; Rancati T; Reyes V; Rosenstein BS; De Ruysscher D; Carmen De Santis M; Seibold P; Sperk E; Veldwijk M; Paul Symonds R; Stobart H; Taboada-Valladares B; Vega A; Veldeman L; Webb AJ; Weltens C; West CM; Rattay T; Talbot CJ;
Radiother Oncol; 2023 Oct; 187():109806. PubMed ID: 37437607
[TBL] [Abstract][Full Text] [Related]
10. Radiation-induced CD8 T-lymphocyte Apoptosis as a Predictor of Breast Fibrosis After Radiotherapy: Results of the Prospective Multicenter French Trial.
Azria D; Riou O; Castan F; Nguyen TD; Peignaux K; Lemanski C; Lagrange JL; Kirova Y; Lartigau E; Belkacemi Y; Bourgier C; Rivera S; Noël G; Clippe S; Mornex F; Hennequin C; Kramar A; Gourgou S; Pèlegrin A; Fenoglietto P; Ozsahin EM
EBioMedicine; 2015 Dec; 2(12):1965-73. PubMed ID: 26844275
[TBL] [Abstract][Full Text] [Related]
11. One versus three weeks hypofractionated whole breast radiotherapy for early breast cancer treatment: the FAST-Forward phase III RCT.
Brunt AM; Haviland JS; Wheatley DA; Sydenham MA; Bloomfield DJ; Chan C; Cleator S; Coles CE; Donovan E; Fleming H; Glynn D; Goodman A; Griffin S; Hopwood P; Kirby AM; Kirwan CC; Nabi Z; Patel J; Sawyer E; Somaiah N; Syndikus I; Venables K; Yarnold JR; Bliss JM;
Health Technol Assess; 2023 Nov; 27(25):1-176. PubMed ID: 37991196
[TBL] [Abstract][Full Text] [Related]
12. [Trends in the use of primary radiotherapy for cancer in the Netherlands in patients with breast, prostate, rectal and lung tumours].
Struikmans H; Aarts MJ; Jobsen JJ; Koning CC; Poortmans PM; Louwman MW; Coebergh JW
Ned Tijdschr Geneeskd; 2012; 156(12):A4426. PubMed ID: 22436526
[TBL] [Abstract][Full Text] [Related]
13. Assessment of Toxic Effects Associated With Dose-Fractionated Radiotherapy Among Patients With Cancer and Comorbid Collagen Vascular Disease.
Yoon SM; Chu FI; Ruan D; Steinberg ML; Raldow A; Lee P
JAMA Netw Open; 2021 Feb; 4(2):e2034074. PubMed ID: 33599771
[TBL] [Abstract][Full Text] [Related]
14. Treatment time and circadian genotype interact to influence radiotherapy side-effects. A prospective European validation study using the REQUITE cohort.
Webb AJ; Harper E; Rattay T; Aguado-Barrera ME; Azria D; Bourgier C; Brengues M; Briers E; Bultijnck R; Chang-Claude J; Choudhury A; Cicchetti A; De Ruysscher D; De Santis MC; Dunning AM; Elliott RM; Fachal L; Gómez-Caamaño A; Gutiérrez-Enríquez S; Johnson K; Lobato-Busto R; Kerns SL; Post G; Rancati T; Reyes V; Rosenstein BS; Seibold P; Seoane A; Sosa-Fajardo P; Sperk E; Taboada-Valladares B; Valdagni R; Vega A; Veldeman L; Ward T; West CM; Symonds RP; Talbot CJ;
EBioMedicine; 2022 Oct; 84():104269. PubMed ID: 36130474
[TBL] [Abstract][Full Text] [Related]
15. Recent advances in de-intensification of radiotherapy in elderly cancer patients.
Desideri I; Salvestrini V; Livi L
F1000Res; 2020; 9():. PubMed ID: 32518630
[TBL] [Abstract][Full Text] [Related]
16. Preliminary report of toxicity following 3D radiation therapy for prostate cancer on 3DOG/RTOG 9406.
Michalski JM; Purdy JA; Winter K; Roach M; Vijayakumar S; Sandler HM; Markoe AM; Ritter MA; Russell KJ; Sailer S; Harms WB; Perez CA; Wilder RB; Hanks GE; Cox JD
Int J Radiat Oncol Biol Phys; 2000 Jan; 46(2):391-402. PubMed ID: 10661346
[TBL] [Abstract][Full Text] [Related]
17. Breast cancer patient perspective on opportunities and challenges of a genetic test aimed to predict radio-induced side effects before treatment: Analysis of the Italian branch of the REQUITE project.
Bellardita L; Colciago RR; Frasca S; De Santis MC; Gay S; Palorini F; La Rocca E; Valdagni R; Rancati T; Lozza L
Radiol Med; 2021 Oct; 126(10):1366-1373. PubMed ID: 34268681
[TBL] [Abstract][Full Text] [Related]
18. Hypofractionated versus conventionally fractionated radiotherapy for patients with prostate cancer (HYPRO): late toxicity results from a randomised, non-inferiority, phase 3 trial.
Aluwini S; Pos F; Schimmel E; Krol S; van der Toorn PP; de Jager H; Alemayehu WG; Heemsbergen W; Heijmen B; Incrocci L
Lancet Oncol; 2016 Apr; 17(4):464-474. PubMed ID: 26968359
[TBL] [Abstract][Full Text] [Related]
19. [Predictors of asthenia in breast and prostate cancer patients undergoing curative radiotherapy].
Guillaume E; Daguenet E; Lahmamssi C; Ben Mrad M; Jmour O; Langrand-Escure J; Rehailia-Blanchard A; Vial N; Pigné G; Bard-Reboul S; Maison M; Tinquaut F; Vallard A; Magné N
Cancer Radiother; 2020 Feb; 24(1):15-20. PubMed ID: 31983629
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
